Profound Medical Corp. Balance Sheet
PROF|2 years of annual SEC 10-K data (FY2024-FY2025)
Shows total assets, cash and equivalents, receivables, property and equipment, total debt, and shareholders' equity across 2 fiscal years. All figures from audited SEC 10-K filings.
Profound Medical Corp. had $77M in total assets and $60M in shareholders' equity as of FY2025. Total debt was $5M against $60M in cash, resulting in a $55M net cash position.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score 0.95 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2025 | FY2024 |
|---|---|---|
| Cash & Equivalents | $59.7M | $54.9M |
| Inventory | $8.2M | $5.8M |
| Current Assets | $76.1M | $69.1M |
| PP&E (Net) | $698.0K | $425.0K |
| Total Assets | $77.5M | $70.2M |
| Current Liabilities | $6.1M | $6.6M |
| Total Debt | $4.7M | $7.1M |
| Shareholders' Equity | $60.4M | $31.2M |